본문 바로가기 주메뉴 바로가기
Introduction
CTCBIO, a company that studies and challenges human happiness and health

History

2020 ~
  • 2020.05
    COVID-19 Diagnosis Kit approved for export by MFDS (Ministry of Food & Drug Safety)
2010~2019
  • 2019. 04
    Establishment of the subsidiary company, CTC VAC Co., Ltd. (Split-off)
  • 2019. 03
    Establishment of the subsidiary company, CTC Science Co., Ltd.
  • 2016. 01
    Feed enzyme preparation of CTCZYME approved by FDA (USA)
  • 2015. 06
    License agreement with multi-national pharmaceutical group, ABBOTT
  • 2015. 02
    Contract for transfer of technology with Swiss pharmaceutical group, FERRING
  • 2014. 12
    Domestic license agreement with Italian pharmaceutical group, MERARINI
  • 2014. 12
    Completion of the Hongcheon Plant
  • 2014. 09
    Acquired the Ansan Plant of SK Chemical
  • 2013. 07
    Selected as a venture company with KRW 100 billion in sales
  • 2012. 12
    Won the Grand Prize in the Korea New Growth Management Awards 2012
  • 2012. 12
    Supply contract of film-type erectile dysfunction drug with global pharmaceutical group
  • 2012. 09
    Joint partnership agreement on global business with Catalent (USA)
  • 2010. 11
    Awarded the Export Tower of 5 million dollars
  • 2010. 09
    Establishment of the subsidiary company, CTC Green Co., Ltd.
2000~2009
  • 2009. 11
    Awarded the Export Tower of 3 million dollars
  • 2009. 10
    Issue of Bond with Warrant (BW) on KRW 20 billion
  • 2009. 03
    CTCZYME awarded the Jang Young Sil Award
  • 2008. 12
    CTCZYME selected as the Global No. 1 Product
  • 2007. 04
    Acquired animal drug business sector of LG Life Sciences
  • 2004. 09
    KGMP (Korea Good Manufacturing Practice) certification by KFDA
  • 2004. 04
    Pharmaceutical Manufacturing Business License acquired
  • 2004. 01
    MOU signed with BASF
  • 2003. 10
    Completion of the Hwaseong Plant
  • 2002. 02
    Listed in KOSDAQ
  • 2001. 05
    Selected as a company for performing the national project
  • 2001. 01
    Certified as Outstanding Venture Company
  • 2000. 09
    Company name changed to CTCBIO Co., Ltd.
1993~1999
  • 1999. 12
    Accomplished annual sales of KRW 20 billion
  • 1999. 08
    Veterinary Drug Manufacturing Business License acquired
  • 1999. 02
    Completion of the Gimhae Plant
  • 1997. 12
    Establishment of the R&D Center
  • 1996. 04
    Technical partnership with ELANCO
  • 1995. 12
    Incorporation to Sechuk Co., Ltd.
  • 1993. 06
    Establishment of Sechuk International